These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23606868)

  • 21. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.
    Jiang Y; Patel CD; Manivanh R; North B; Backes IM; Posner DA; Gilli F; Pachner AR; Nguyen LN; Leib DA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28679745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways.
    Zheng W; Xu Q; Zhang Y; E X; Gao W; Zhang M; Zhai W; Rajkumar RS; Liu Z
    Virol J; 2020 Dec; 17(1):192. PubMed ID: 33298111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
    Wagstaff AJ; Faulds D; Goa KL
    Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
    Chan T; Barra NG; Lee AJ; Ashkar AA
    J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1.
    Zhu H; Zheng C
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 32998978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal herpes simplex virus infection: epidemiology and treatment.
    James SH; Kimberlin DW
    Clin Perinatol; 2015 Mar; 42(1):47-59, viii. PubMed ID: 25677996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population.
    Akhtar LN; Bowen CD; Renner DW; Pandey U; Della Fera AN; Kimberlin DW; Prichard MN; Whitley RJ; Weitzman MD; Szpara ML
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30814317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
    Gill N; Davies EJ; Ashkar AA
    Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic basis for increased susceptibility of the neonate to infection.
    Wilson CB
    J Pediatr; 1986 Jan; 108(1):1-12. PubMed ID: 3511202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human inborn errors of immunity to herpes viruses.
    Jouanguy E; Béziat V; Mogensen TH; Casanova JL; Tangye SG; Zhang SY
    Curr Opin Immunol; 2020 Feb; 62():106-122. PubMed ID: 32014647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of suspected neonatal herpes simplex virus infection in preterm versus term newborns in the neonatal intensive care unit.
    Fernandes N; Sthapit B; Mhanna M; Abughali N
    J Neonatal Perinatal Med; 2020; 13(3):387-394. PubMed ID: 32083595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal stridor in association with herpes simplex infection of the larynx.
    Sharp HR; Blaney SP; Morrison GA
    J Laryngol Otol; 1998 Dec; 112(12):1192-3. PubMed ID: 10209621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
    Kohl S; West MS; Prober CG; Sullender WM; Loo LS; Arvin AM
    J Infect Dis; 1989 Nov; 160(5):770-6. PubMed ID: 2553825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of antibody to outcome in neonatal herpes simplex virus infections.
    Yeager AS; Arvin AM; Urbani LJ; Kemp JA
    Infect Immun; 1980 Aug; 29(2):532-8. PubMed ID: 7216423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genital herpes.
    Gupta R; Warren T; Wald A
    Lancet; 2007 Dec; 370(9605):2127-37. PubMed ID: 18156035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.
    James SH; Whitley RJ
    Clin Pharmacol Ther; 2010 Nov; 88(5):720-4. PubMed ID: 20881952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and potential therapies for the treatment of herpes-virus infections.
    Villarreal EC
    Prog Drug Res; 2003; 60():263-307. PubMed ID: 12790345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.
    Zhang J; Liu H; Wei B
    J Zhejiang Univ Sci B; 2017 Apr.; 18(4):277-288. PubMed ID: 28378566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.